↑Zhang Y, Feng X, We R, Derynck R (September 1996). "Receptor-associated Mad homologues synergize as effectors of the TGF-beta response". Nature. 383 (6596): 168–72. doi:10.1038/383168a0. PMID8774881.
↑Moustakas A, Souchelnytskyi S, Heldin CH (December 2001). "Smad regulation in TGF-beta signal transduction". Journal of Cell Science. 114 (Pt 24): 4359–69. PMID11792802.
↑Huang S, Liao Q, Li L, Xin D (July 2014). "PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation". Tumour Biology. 35 (7): 6265–70. doi:10.1007/s13277-014-1818-z. PMID24627133.
↑Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z (October 2007). "Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice". Clinical Cancer Research. 13 (19): 5692–702. doi:10.1158/1078-0432.CCR-07-1078. PMID17908958.
↑Hachimine D, Uchida K, Asada M, Nishio A, Kawamata S, Sekimoto G, Murata M, Yamagata H, Yoshida K, Mori S, Tahashi Y, Matsuzaki K, Okazaki K (June 2008). "Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice". International Journal of Oncology. 32 (6): 1221–6. doi:10.3892/ijo.32.6.1221. PMID18497983.
↑Kawamata S, Matsuzaki K, Murata M, Seki T, Matsuoka K, Iwao Y, Hibi T, Okazaki K (March 2011). "Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis". Inflammatory Bowel Diseases. 17 (3): 683–95. doi:10.1002/ibd.21395. PMID20602465.
↑Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P (March 2010). "Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis". Oncogene. 29 (9): 1351–61. doi:10.1038/onc.2009.426. PMID20010874.
↑Meng XM, Chung AC, Lan HY (February 2013). "Role of the TGF-β/BMP-7/Smad pathways in renal diseases". Clinical Science. 124 (4): 243–54. doi:10.1042/CS20120252. PMID23126427.
Li H, Liu JP (October 2007). "Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene". Annals of the New York Academy of Sciences. 1114: 56–68. doi:10.1196/annals.1396.016. PMID17934056.
Matsuzaki K (June 2006). "Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis". Histology and Histopathology. 21 (6): 645–62. doi:10.14670/HH-21.645. PMID16528675.
Walker LC, Waddell N, Ten Haaf A, Grimmond S, Spurdle AB (November 2008). "Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers". Breast Cancer Research and Treatment. 112 (2): 229–36. doi:10.1007/s10549-007-9848-5. PMID18095154.
Lee KB, Jeon JH, Choi I, Kwon OY, Yu K, You KH (February 2008). "Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability". Biochemical and Biophysical Research Communications. 366 (4): 905–9. doi:10.1016/j.bbrc.2007.12.033. PMID18082619.
Kim TD, Shin S, Janknecht R (February 2008). "Repression of Smad3 activity by histone demethylase SMCX/JARID1C". Biochemical and Biophysical Research Communications. 366 (2): 563–7. doi:10.1016/j.bbrc.2007.12.013. PMID18078810.
Zhao X, Nicholls JM, Chen YG (February 2008). "Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling". The Journal of Biological Chemistry. 283 (6): 3272–80. doi:10.1074/jbc.M708033200. PMID18055455.
Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z (October 2007). "Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice". Clinical Cancer Research. 13 (19): 5692–702. doi:10.1158/1078-0432.CCR-07-1078. PMID17908958.
Zhang M, Lee CH, Luo DD, Krupa A, Fraser D, Phillips A (September 2007). "Polarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-catenin". The Journal of Biological Chemistry. 282 (39): 28639–47. doi:10.1074/jbc.M700594200. PMID17623674.